Last Updated:December 07, 2025, 08:34 IST Biocon plans to merge Biocon Biologics Limited, acquiring stakes from Mylan, Serum Institute Life…
Read More
Biocon Biologics secures market enattempt date for Denosumab biosimilars in Europe, Rest of the World
News Biocon Biologics secures market enattempt date for Denosumab biosimilars in Europe, Rest of the World The agreement allows Biocon…
Read More
GenSight Biologics Announces Successful Fundraising Amounting to Nearly EUR 3.7 Million
PARIS, September 26, 2025–(BUSINESS WIRE)–Regulatory News: NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA,…
Read More
Aurobindo Pharma’s CuraTeQ Biologics secures UK MHRA approval for biosimilar Dazublys
Aurobindo Pharma Limited announced that its step-down subsidiary, CuraTeQ Biologics s.r.o., has received marketing authorisation from the UK’s Medicines and…
Read More
Biocon Biologics posts strong Q1 growth as North America, Europe deliver
Biocon Biologics Ltd, the biosimilars unit of biopharmaceutical giant Biocon and its largest revenue driver, expects to accelerate growth after…
Read More
